Concourse Financial Group Securities’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5556 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6402 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6400 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6419 |
|
|
2024
Q1 | – | Sell |
-7
| Closed | -$104 | – | 6417 |
|
|
2023
Q4 | $104 | Buy |
7
+6
| +600% | +$89 | ﹤0.01% | 2240 |
|
|
2023
Q3 | $16 | Sell |
1
-74
| -99% | -$1.18K | ﹤0.01% | 2293 |
|
|
2023
Q2 | $3.11K | Hold |
75
| – | – | ﹤0.01% | 1938 |
|
|
2023
Q1 | $4.51K | Hold |
75
| – | – | ﹤0.01% | 1893 |
|
|
2022
Q4 | $5.5K | Buy |
+75
| New | +$5.5K | ﹤0.01% | 1821 |
|
|
2022
Q3 | – | Sell |
-125
| Closed | -$9K | – | 5667 |
|
|
2022
Q2 | $9K | Hold |
125
| – | – | ﹤0.01% | 1690 |
|
|
2022
Q1 | $10K | Sell |
125
-321
| -72% | -$25.7K | ﹤0.01% | 1689 |
|
|
2021
Q4 | $33K | Buy |
446
+4
| +0.9% | +$296 | ﹤0.01% | 1454 |
|
|
2021
Q3 | $51K | Buy |
442
+233
| +111% | +$26.9K | ﹤0.01% | 1295 |
|
|
2021
Q2 | $46K | Hold |
209
| – | – | ﹤0.01% | 1345 |
|
|
2021
Q1 | $28K | Hold |
209
| – | – | ﹤0.01% | 1451 |
|
|
2020
Q4 | $36K | Sell |
209
-18
| -8% | -$3.1K | ﹤0.01% | 1251 |
|
|
2020
Q3 | $25K | Hold |
227
| – | – | ﹤0.01% | 1291 |
|
|
2020
Q2 | $13K | Hold |
227
| – | – | ﹤0.01% | 1426 |
|
|
2020
Q1 | $15K | Buy |
227
+5
| +2% | +$330 | ﹤0.01% | 1338 |
|
|
2019
Q4 | $19K | Buy |
222
+13
| +6% | +$1.11K | ﹤0.01% | 1268 |
|
|
2019
Q3 | $16K | Buy |
209
+129
| +161% | +$9.88K | ﹤0.01% | 1028 |
|
|
2019
Q2 | $5K | Buy |
+80
| New | +$5K | ﹤0.01% | 1742 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4436 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4311 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4038 |
|